Weight-loss medications are one of the most talked-about topics in healthcare—and Medicare is stepping into the conversation in a big way.
Starting July 1, 2026, CMS is launching the Medicare GLP-1 Bridge, a short-term demonstration program designed to expand access to weight-management GLP-1 medications for eligible beneficiaries.